MYCN and neuroblastoma: Two compounds, 10058‐F4 and 10074‐G5, have been found to block heterodimerization, and treatment of MYCN‐amplified models of NB with these compounds induced differentiation and apoptosis in vitro conditions, and suppressed the growth of xenograft tumors.151, 152, 153